Trial Details

COMPLETED
Basic Information
Clinical ID c3216
Identifier NCT02378688
Trial Title Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: MT-1303|DRUG: Placebo
Participant Information
Sponsor Tanabe Pharma Corporation
City City Name
Country/Region Czechia
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2015-03
Primary Completion Date 2016-10
Completion Date 2016-10